[Clinical evaluation of eribulin mesylate for the treatment of metastatic breast cancer].
Matsuzaki H, Tohnosu N, Yoshiwara C, Maruyama T, Tanaka H, Natsume T, Miyazaki A, Sato Y, Ohta T, Yamamoto Y, Aikawa M, Ohtsuka R, Yanagihara A, Iwata K, Shiratori T, Miyazawa Y.
Matsuzaki H, et al. Among authors: sato y.
Gan To Kagaku Ryoho. 2014 Apr;41(4):455-9.
Gan To Kagaku Ryoho. 2014.
PMID: 24743360
Japanese.